Explain 10 common heart disease

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I have enough from the textbooks. Now I'll compile the comprehensive answer:

10 Common Heart Diseases

Here is a detailed breakdown of 10 of the most prevalent and clinically significant heart diseases, drawing from Braunwald's Heart Disease, Robbins & Kumar Basic Pathology, Textbook of Family Medicine, Lippincott Illustrated Reviews: Pharmacology, Goldman-Cecil Medicine, and other authoritative sources.

1. Coronary Artery Disease (CAD)

Also called: Ischemic heart disease

What it is: CAD is the single leading cause of cardiovascular morbidity and death worldwide. It results from atherosclerotic plaque buildup in the coronary arteries, narrowing the lumen and reducing blood flow to the myocardium.

Pathophysiology: An imbalance between myocardial oxygen supply and demand is the core mechanism. Atherosclerotic plaques develop over years; when a plaque ruptures, a thrombus forms and can suddenly occlude a vessel - producing an acute coronary syndrome (unstable angina or myocardial infarction).

Symptoms:

Stable angina: chest pressure, tightness, or heaviness with exertion, relieved by rest or nitroglycerin
Unstable angina: chest pain at rest or with increasing frequency/severity not relieved by rest
Myocardial infarction (heart attack): severe crushing chest pain, radiating to the arm or jaw, with sweating, nausea, shortness of breath. Atypical presentations (fatigue, nausea, no chest pain) are more common in women, elderly, and diabetics

Risk factors: Hypertension, hyperlipidemia, diabetes, smoking, obesity, family history, sedentary lifestyle

Management: Lifestyle modification, statins, aspirin, beta-blockers, nitrates, ACE inhibitors. Revascularization via percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for severe cases.

Lippincott Illustrated Reviews: Pharmacology, pp. 424-425; Textbook of Family Medicine 9e

2. Heart Failure (HF)

What it is: Heart failure is a clinical syndrome in which the heart cannot meet the body's metabolic requirements at normal filling pressures. It is highly prevalent - over 650,000 new cases are diagnosed in the United States annually, with a mortality rate approaching 50% within 5 years.

Two main types:

HFrEF (Heart Failure with Reduced Ejection Fraction): EF < 45-50%, impaired LV contraction
HFpEF (Heart Failure with Preserved Ejection Fraction): EF > 45-50%, impaired LV filling/relaxation - almost equally as common as HFrEF

Pathophysiology: Left ventricular remodeling is the key mechanism - the LV stretches and dilates, reducing function. Neurohormonal activation (RAAS, sympathetic nervous system, endothelin-1) drives the remodeling process. Triggers include CAD, MI, hypertension, valvular disease, diabetes, and alcohol.

Symptoms: Dyspnea on exertion, orthopnea (difficulty breathing when lying flat), paroxysmal nocturnal dyspnea, fatigue, leg edema, reduced exercise tolerance. Notably, pulmonary congestion may be absent - "congestive heart failure" is no longer preferred.

Management: ACE inhibitors/ARBs, beta-blockers, mineralocorticoid receptor antagonists (e.g., spironolactone), diuretics for fluid overload, SGLT2 inhibitors, and cardiac resynchronization therapy or devices in selected patients.

Textbook of Family Medicine 9e, pp. 566-579

3. Hypertensive Heart Disease

What it is: Cardiac damage resulting directly from elevated blood pressure. Given that hypertension now affects approximately 50% of the U.S. general population (using the revised threshold of >120/80 mmHg), this is extremely common.

Pathophysiology: Sustained systemic hypertension imposes chronic pressure overload on the left ventricle. The heart compensates through left ventricular hypertrophy (LVH) - the heart weight can exceed 500g (normal ~320-360g for a 60-70 kg person), and LV wall thickness may exceed 2.0 cm (normal 1.2-1.4 cm). Microscopically, myocytes show increased transverse diameter, enlarged "boxcar nuclei," and interstitial fibrosis. Over time, hypertrophied ventricles stiffen, impair diastolic filling, and eventually dilate and fail.

Symptoms: Often asymptomatic initially, discovered incidentally. Can present with atrial fibrillation (from left atrial enlargement), shortness of breath, fatigue, chest pain, or sudden cardiac death.

Complications: Heart failure, ventricular arrhythmias, increased mortality after MI, stroke, sudden cardiac death.

Management: Blood pressure control with antihypertensives (ACE inhibitors, ARBs, thiazides, calcium channel blockers). Effective BP control can lead to regression of LVH.

Robbins & Kumar Basic Pathology, pp. 754-775

4. Atrial Fibrillation (AF)

What it is: The most common sustained cardiac arrhythmia, characterized by chaotic, disorganized electrical activity in the atria, resulting in an irregular ventricular response.

Pathophysiology: Disorganized atrial electrical signals (often originating from pulmonary vein foci) prevent coordinated atrial contraction. The atria quiver rather than pump, leading to blood stasis - particularly in the left atrial appendage - with a significant risk of thrombus formation and systemic embolism.

Symptoms: Palpitations, irregular heartbeat, fatigue, shortness of breath, lightheadedness, reduced exercise tolerance. Some patients are entirely asymptomatic and AF is discovered incidentally.

Key risks:

Stroke: Blood pooling in the fibrillating left atrium forms clots that can embolize to the brain. Stroke risk is estimated using the CHA2DS2-VASc score.
Heart failure: Loss of the atrial "kick" and rapid ventricular rates reduce cardiac output.
Tachycardia-induced cardiomyopathy with prolonged rapid rates

Management: Rate control (beta-blockers, calcium channel blockers, digoxin), rhythm control (antiarrhythmics, cardioversion, catheter ablation), and anticoagulation (direct oral anticoagulants - DOACs - or warfarin) to prevent stroke.

Braunwald's Heart Disease, 2 Vol Set

5. Valvular Heart Disease

What it is: Structural or functional abnormality of one or more heart valves (aortic, mitral, tricuspid, or pulmonic), causing stenosis (obstruction to flow) or regurgitation (backward leakage), or both.

Common types:

Aortic stenosis: Most common valve disease in the elderly; calcification of the aortic valve causes obstruction. Classic triad: angina, syncope, heart failure. Sudden deterioration can occur.
Aortic regurgitation: Backward leakage from the aorta into the LV, causing volume overload.
Mitral stenosis: Usually from rheumatic heart disease; impaired left atrial emptying causes pulmonary congestion.
Mitral regurgitation: Leaflet prolapse, rheumatic disease, or papillary muscle dysfunction causes backward flow into the left atrium.
Mitral valve prolapse (MVP): Billowing of mitral leaflet(s) into the LA during systole; common (2-3% of population), usually benign.

Causes: Rheumatic fever, congenital bicuspid aortic valve, age-related calcification, infective endocarditis, connective tissue disorders.

Symptoms: Dyspnea, angina, syncope, palpitations, edema - depending on the valve and severity.

Management: Medical therapy for symptom control; surgical or transcatheter valve repair or replacement when disease is severe or symptomatic.

Textbook of Family Medicine 9e, pp. 2411-2481; Pye's Surgical Handicraft

6. Cardiomyopathy

What it is: A group of diseases of the heart muscle itself, not caused by coronary artery disease, hypertension, or valvular disease.

Main types:

Dilated cardiomyopathy (DCM): Most common type. LV dilation and systolic dysfunction. Causes: idiopathic (most common), viral myocarditis, alcohol, genetic mutations, peripartum. Presents as progressive heart failure.
Hypertrophic cardiomyopathy (HCM): Genetic (sarcomere protein mutations, autosomal dominant). Asymmetric LV hypertrophy - often involving the septum - with diastolic dysfunction and possible outflow obstruction (HOCM). Leading cause of sudden cardiac death in young athletes.
Restrictive cardiomyopathy: Stiff ventricles with impaired filling; caused by infiltrative diseases (amyloidosis, sarcoidosis, hemochromatosis) or fibrosis.
Arrhythmogenic right ventricular cardiomyopathy (ARVC): Fatty/fibrous replacement of RV myocardium; predisposes to ventricular arrhythmias and sudden death.
Alcoholic cardiomyopathy: Direct toxic effect of ethanol on myocytes.

Symptoms: Dyspnea, fatigue, chest pain, palpitations, syncope, and in advanced disease, symptoms of heart failure. HCM may cause sudden cardiac death as the first presentation.

Management: Depends on type; includes heart failure medications, antiarrhythmics, implantable defibrillators (ICD), or heart transplantation.

Pfenninger and Fowler's Procedures for Primary Care, pp. 1740-1747

7. Congenital Heart Disease (CHD)

What it is: Structural heart defects present from birth, resulting from abnormal cardiac development during fetal life. CHD is the most common congenital malformation, occurring in roughly 1% of live births.

Common defects:

Ventricular septal defect (VSD): Opening between the ventricles; most common congenital heart defect.
Atrial septal defect (ASD): Opening between the atria; may be undetected until adulthood.
Patent ductus arteriosus (PDA): Failure of the ductus arteriosus (connecting the aorta and pulmonary artery) to close after birth.
Tetralogy of Fallot: Complex defect with four components - VSD, right ventricular outflow obstruction, overriding aorta, RV hypertrophy. Most common cyanotic CHD.
Coarctation of the aorta: Narrowing of the aorta.
Transposition of the great arteries: Aorta and pulmonary artery are switched.

Symptoms: Cyanosis (blue discoloration), poor feeding, failure to thrive, shortness of breath, murmur, clubbing of fingers/toes (in chronic cyanosis). Left-to-right shunts cause pulmonary overcirculation; right-to-left shunts cause cyanosis.

Complication: Pulmonary vascular disease (Eisenmenger syndrome) can develop if high-pressure left-to-right shunts are not repaired, causing irreversible pulmonary hypertension.

Management: Many defects are repaired surgically or via catheter-based interventions, ideally in infancy or early childhood to prevent pulmonary vascular complications.

Pye's Surgical Handicraft, pp. 6624-6643; Murray & Nadel's Textbook of Respiratory Medicine

8. Pericarditis

What it is: Inflammation of the pericardium (the fibrous sac surrounding the heart). It is the most common pericardial disease encountered clinically.

Causes:

Idiopathic/viral (most common in developed countries) - often Coxsackievirus, echovirus, adenovirus
Autoimmune/connective tissue disease - SLE, rheumatoid arthritis, systemic sclerosis
Bacterial (especially tuberculosis in developing countries)
Post-MI (Dressler syndrome)
Uremia, malignancy, medications

Symptoms:

Sharp, pleuritic chest pain - characteristically worse when lying flat and improved by leaning forward
Pericardial friction rub on auscultation
Dyspnea
ECG changes: diffuse saddle-shaped ST elevation followed by PR depression

Complications:

Pericardial effusion (fluid around the heart)
Cardiac tamponade (life-threatening compression of the heart by fluid)
Constrictive pericarditis (chronic scarring and stiffening of the pericardium)

Management: NSAIDs + colchicine as first-line therapy; corticosteroids for refractory cases; pericardiocentesis for tamponade; pericardiectomy for constrictive disease.

Braunwald's Heart Disease

9. Myocarditis

What it is: Inflammation of the myocardium (heart muscle itself), distinct from the pericardium. It is an important and underdiagnosed cause of acute heart failure, arrhythmias, and dilated cardiomyopathy.

Causes:

Viral (most common): Coxsackievirus B, parvovirus B19, adenovirus, influenza, HIV, and more recently SARS-CoV-2
Bacterial, protozoal (e.g., Chagas disease - Trypanosoma cruzi - a leading cause in Latin America)
Autoimmune: Systemic lupus, giant cell myocarditis
Drugs/toxins: Chemotherapy agents (anthracyclines), immune checkpoint inhibitors, cocaine
Hypersensitivity reactions: DRESS (drug reaction with eosinophilia and systemic symptoms)

Symptoms: Range from mild (flu-like illness with palpitations) to severe (acute heart failure, cardiogenic shock, life-threatening arrhythmias). Chest pain, dyspnea, fatigue, and syncope are common.

Diagnosis: Troponin elevation, ECG changes, echocardiography, cardiac MRI (gold standard non-invasive), endomyocardial biopsy (definitive).

Management: Supportive care (heart failure therapy, antiarrhythmics), immunosuppression for autoimmune and giant cell myocarditis; advanced therapies (mechanical circulatory support, transplantation) for fulminant disease.

Fuster and Hurst's The Heart, 15th Ed.; Harrison's Principles of Internal Medicine 22E

10. Peripheral Artery Disease (PAD)

What it is: Atherosclerotic narrowing of the arteries supplying the limbs (predominantly the lower extremities), reducing blood flow. PAD is a strong marker of systemic atherosclerosis and is associated with high cardiovascular event risk.

Pathophysiology: Same atherosclerotic process as CAD - plaque formation, lumen narrowing, and reduced blood flow to the extremities. Risk factors are identical: diabetes, smoking, hypertension, hyperlipidemia, older age.

Symptoms:

Intermittent claudication (classic): reproducible cramping pain in the calf, thigh, or buttock with walking, relieved by rest
Critical limb ischemia: rest pain (especially at night), non-healing ulcers, gangrene - represents severe disease threatening limb loss
Many patients are asymptomatic despite significant disease

Diagnosis: Ankle-brachial index (ABI) - ratio of ankle to brachial blood pressure; an ABI < 0.9 is diagnostic of PAD.

Management:

Risk factor modification (smoking cessation is the single most important intervention, statins, BP control, diabetic management)
Antiplatelet therapy (aspirin or clopidogrel)
Supervised exercise programs (most evidence-based for claudication)
Revascularization (angioplasty/stenting or bypass surgery) for critical limb ischemia or disabling claudication
Goldman-Cecil Medicine International Edition; Textbook of Family Medicine 9e

Quick Comparison Table

Disease	Primary Site	Key Symptom	Main Risk/Cause
Coronary Artery Disease	Coronary vessels	Chest pain/angina	Atherosclerosis
Heart Failure	LV/RV muscle	Dyspnea, edema	CAD, hypertension
Hypertensive Heart Disease	LV wall	Often silent → HF	High blood pressure
Atrial Fibrillation	Atria	Palpitations, stroke	Hypertension, aging
Valvular Heart Disease	Heart valves	Dyspnea, murmur	Rheumatic fever, aging
Cardiomyopathy	Myocardium	HF, sudden death	Idiopathic, genetic, toxins
Congenital Heart Disease	Any structure	Cyanosis, murmur	Developmental defect
Pericarditis	Pericardium	Pleuritic chest pain	Viral, autoimmune
Myocarditis	Myocardium	HF, arrhythmia	Viral, autoimmune
Peripheral Artery Disease	Limb arteries	Leg claudication	Atherosclerosis

Sources: Textbook of Family Medicine 9e; Robbins & Kumar Basic Pathology; Braunwald's Heart Disease, A Textbook of Cardiovascular Medicine; Lippincott Illustrated Reviews: Pharmacology; Goldman-Cecil Medicine; Fuster and Hurst's The Heart, 15th Ed.; Harrison's Principles of Internal Medicine 22E; Pye's Surgical Handicraft

This is a shared conversation. Sign in to Orris to start your own chat.